Mariana reels in $175M for radiopharmaceutical …

Novartis entrenches into radiopharma with $1B Mariana buy - Fierce BiotechNovartis knows what's ahead as peers enter radiopharmaceuticalsNovartis, Lilly drive investor interest in radiopharmaceuticals

CouponFollow Extension

$175
OFF

Mariana Reels In $175M For Radiopharmaceutical …

4 weeks from now

fiercebiotech.com

$175
OFF

Startup Mariana Raises $175M For Radiopharmaceutical Drug Research

4 weeks from now

Sep 7, 2023 · Its participation in Mariana’s Series B is the first investment from that new fund, called the Forbion Ventures Fund VI. Mariana, based in Cambridge, Massachusetts, plans to …

biopharmadive.com

$175
OFF

With $175m, Mariana Will Take First Precision ... - Scrip

4 weeks from now

Sep 7, 2023 · Mariana Oncology closed a $175m series B venture capital round to fund its first clinical trial, for MC-339 in small-cell lung cancer, as well as its manufacturing and pipeline …

citeline.com

$175
OFF

Startup Radiopharmaceutical Developer Mariana Oncology Raises …

4 weeks from now

Sep 11, 2023 · Mariana Oncology has raised $175 million in new capital, the Cambridge, Massachusetts-based radiopharmaceutical developer announced Sept. 7. Investment firms …

radiologybusiness.com

$175
OFF

Mariana Oncology’s Radiopharm Platform Acquired By Novartis

4 weeks from now

May 6, 2024 · Mariana’s COO/CFO Linda Bain was the final member of the senior leadership team to join, and helped scale the company into its $175M Series B raise last fall, in …

lifescivc.com

$1.75
OFF

Mariana Oncology To Be Acquired By Novartis To Advance …

4 weeks from now

May 2, 2024 · Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion …

marianaoncology.com

$175
OFF

Mariana Oncology Announces $175 Million Series B Financing

4 weeks from now

Sep 7, 2023 · “The promising nature of Mariana Oncology’s pipeline is particularly exciting when we look at the possible positive impact on patients,” said Geert-Jan Mulder, M.D., Managing …

businesswire.com

$175
OFF

Novartis, Lilly Drive Investor Interest In Radiopharmaceuticals

4 weeks from now

Dec 8, 2023 · The company also contributed to Mariana Oncology’s $175 ... Venture financing for U.S.-based radiopharmaceutical companies hit $1.2 billion between 2018 and 2023, with the …

fiercebiotech.com

$175
OFF

Mariana Oncology Raises $175 Million | C&EN Global Enterprise

4 weeks from now

Sep 11, 2023 · Mariana Oncology, a Massachusetts-based developer of radiopharmaceuticals to treat cancer, has raised $175 million in series B financing. Eli Lilly and Company is among the …

acs.org

$1
OFF

Forbion Portfolio Company Mariana Oncology To Be Acquired By …

4 weeks from now

May 2, 2024 · • Latest deal marks the fifth Forbion portfolio company to be acquired for over $1 bn within a year. Naarden, The Netherlands, 2 May 2024 - Forbion portfolio company Mariana …

forbion.com

$175
OFF

Radiopharma Alpha-9 Raises $175M Series C To Fund Clinical Push

4 weeks from now

Oct 23, 2024 · Alpha-9 Oncology has raised a $175 million series C round to bankroll its clinical-stage radiopharmaceutical drugs, although the exact details of the biotech’s pipeline remain …

fiercebiotech.com

FAQs about Mariana reels in $175M for radiopharmaceutical … Coupon?

What happened to Mariana oncology?

WATERTOWN, Mass., September 7, 2023 – Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat cancers with high unmet need, today announced the closing of an oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion. ...

What makes Mariana oncology different from other radiopharmaceutical companies?

“Mariana Oncology’s pipeline is innovative and differentiated from most existing radiopharmaceutical companies. We are compelled by the broader opportunity for radiopharmaceuticals beyond prostate cancer and look forward to supporting Mariana Oncology’s success along with their seasoned leadership team and strong syndicate.” ...

How much did Mariana oncology raise in a series B round?

Mariana Oncology, a biotechnology company developing radiopharmaceuticals for cancer, raised $175 million in their Series B round. The fundraising, announced by Mariana Thursday, was led by Deep Track Capital and Forbion, a European venture capital firm that recently raised more than $800 million to invest in young biotechs. ...

What is Mariana's Series B investment?

Mariana raised $175M in their Series B investment, which is the first investment from their new fund, called the Forbion Ventures Fund VI. Based in Cambridge, Massachusetts, Mariana plans to use the new money to advance a pipeline of radiopharmaceutical drugs into clinical testing, including its lead candidate for small cell lung cancer. ...

Who owns Mariana oncology?

This follows an oversubscribed $175 million Series B financing in Mariana Oncology in September 2023 co-led by Forbion and Deep Track Capital, alongside founding investors Atlas Venture, Access Biotechnology, RA Capital Management and new investors Nextech Invest, Surveyor Capital (a Citadel company) and Eli Lilly and Company. ...

What makes Mariana oncology unique?

Together, we offer a compelling combination of capabilities,” said Simon Read, Founder and CEO, Mariana Oncology. “In the short time since founding the company, the team at Mariana Oncology has developed a leading radiopharmaceutical discovery platform and an innovative pipeline. ...